HOME > Investors >
Press Releases
2018-05-10
Global Market Report Forecasts ViroMed’s VM202 Will Become First Disease-Modifying Drug for PDPN
2018-04-17
ViroMed’s DPN Clinical Trial Passes 70% Point in Patient Randomization
2018-04-17
ViroMed Announces Publication of VM202’s MoA in Reducing Neuropathic Pain
2018-04-12
AARP Calls ViroMed’s VM202 “Hope” for Peripheral Neuropathy
2018-04-11
Government to Build Big Data and Plant Map of the Korean Peninsula by 2025
1
2
3
4
5
6
7
8
9
10
